Live
- ‘First day, first show’ now from home
- ‘Victim of capitalism’ Kangana Ranaut says ‘bye bye’ to airport looks
- Ayushmann: Nation-building starts from being inclusive as a society
- Anushka Sharma, Virat Kohli to attend FA Cup Final in London
- OTT release of romance drama ‘Jee Karda’ starring Tamannaah on June 15
- Ileana shares first glimpse of boyfriend since pregnancy announcement
- 'PS-2' now free to watch on Amazon Prime Video
- Haryana BJP MP Joins Anil Vij In Tweeting Support For Vinesh Phogat, Sakshi Malik, and Bajrang Punia
- Rapo’s tweet makes fans elate
- AP Fibernet starts First Day First Show concept, people can now watch movies at home
Russian Covid vax arrives in India for human clinical trial
Russian Covid vax arrives in India for human clinical trial
The Russian 'Sputnik V' vaccine for Covid-19 has arrived in India following the nod to Pharma major Dr Reddy's Laboratories to conduct an adaptive phase 2/3 human clinical trial for the vaccine in the country.
New Delhi: The Russian 'Sputnik V' vaccine for Covid-19 has arrived in India following the nod to Pharma major Dr Reddy's Laboratories to conduct an adaptive phase 2/3 human clinical trial for the vaccine in the country.
In a video that surfaced on media, containers with logos of Dr Reddy's and Sputnik V being unloaded from a small truck was seen.
On Wednesday, Russia's National Research Centre for Epidemiology and Microbiology and the Russian Direct Investment Fund announced that the Sputnik V vaccine demonstrated high efficacy -- 92 per cent.
On September 4, The Lancet, one of world's leading medical journals, published a research paper on the results of Phase I and Phase II clinical trials of the vaccine that showed no serious adverse events and effective immune response of those vaccinated.
Requests for more than 1.2 billion doses of Sputnik V vaccine came from over 50 countries. The vaccine supplies for the global market will be produced by RDIF's international partners in India, Brazil, China, South Korea and other countries Earlier this October, Dr Reddy's and Russia Direct Investment Fund (RDIF) received approval from the Drugs Controller General of India (DCGI) to conduct an adaptive phase 2/3 human clinical trial for the Sputnik V vaccine in India.
"The government is committed to fast-track clinical development of COVID vaccine candidates and provide facilitation to accelerate market readiness of a suitable vaccine," said Renu Swarup, Secretary, DBT and Chairperson, BIRAC.
